Open access · OA
via OpenAlex
Fasting and differential chemotherapy protection in patients
Lizzia Raffaghello, Fernando Martin Safdie, Giovanna Bianchi, Tanya Barauskas Dorff, Luigi Fontana, Valter Daniel Longo
Cell Cycle · 2010 · ▲ 115 citations
Abstract
Chronic calorie restriction has been known for decades to prevent or retard cancer growth, but its weight-loss effect and the potential problems associated with combining it with chemotherapy have prevented its clinical application. Based on the discovery in model organisms that short term starvation (STS or fasting) causes a rapid switch of cells to a protected mode, we described a fasting-based intervention that causes remarkable changes in the levels of glucose, IGF-I and many other proteins and molecules and is capable of protecting mammalian cells and mice from various toxins, including chemotherapy. Because oncogenes prevent the cellular switch to this stress resistance mode, starvation for 48 hours or longer protects normal yeast and mammalian cells and mice but not cancer cells from chemotherapy, an effect we termed Differential Stress Resistance (DSR). In a recent article, 10 patients who fasted in combination with chemotherapy, reported that fasting was not only feasible and safe but caused a reduction in a wide range of side effects accompanied by an apparently normal and possibly augmented chemotherapy efficacy. Together with the remarkable results observed in animals, these data provide preliminary evidence in support of the human application of this fundamental biogerontology finding, particularly for terminal patients receiving chemotherapy. Here we briefly discuss the basic, pre-clinical, and clinical studies on fasting and cancer therapy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.4161/cc.9.22.13954
- Canonical
- link ↗
- Fetched
- 2026-09-28 MST
Cite this
APA
Raffaghello, L., Safdie, F.M., Bianchi, G., Dorff, T.B., Fontana, L., & Longo, V.D. (2010). Fasting and differential chemotherapy protection in patients. <em>Cell Cycle</em>. https://doi.org/10.4161/cc.9.22.13954
Vancouver
Raffaghello L, Safdie FM, Bianchi G, Dorff TB, Fontana L, Longo VD. Fasting and differential chemotherapy protection in patients. Cell Cycle. 2010. doi:10.4161/cc.9.22.13954.
BibTeX
@article{lizzia2010Fastin,
title = {Fasting and differential chemotherapy protection in patients},
author = {Lizzia Raffaghello and Fernando Martin Safdie and Giovanna Bianchi and Tanya Barauskas Dorff and Luigi Fontana and Valter Daniel Longo},
journal = {Cell Cycle},
year = {2010},
doi = {10.4161/cc.9.22.13954},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Skeletal Muscle 2016
Open access · CC-BY
Voluntary resistance wheel exercise from mid-life prevents sarcopenia and increases markers of mitochondrial function and autophagy in muscles of old male and female C57BL/6J mice
NORA - Norwegian Open Research Archives 2012
Preprint · OA
The effect of hyperbaric oxygen treatment, alone or in combination with 5-FU, on a MDA-MB-231 human mammary tumor model
Scientific Reports 2025
Open access · CC-BY
The adverse effects of chemotherapy on bone mass are not prevented by senolytics
JNCI Journal of the National Cancer Institute 2008
Citation only
Understanding Pathways of Calorie Restriction: A Way To Prevent Cancer?
The journals of gerontology. Series A, Biological sciences and medical sciences 2026
Citation only
The association of frailty with age and lifespan in mice differs by strain and sex.
New England Journal of Medicine 2009
Open access · OA